Phase 2 X-Linked Retinitis Pigmentosa Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 2

A Phase 2 Open-label Study to Evaluate the Safety of Laruparetigene Zovaparvovec Administered Bilaterally in Male Participants With X-Linked Retinitis Pigmentosa

X-Linked Retinitis Pigmentosa (XLRP)

Beacon Therapeutics10 enrolled6 locationsNCT07174726

Recruiting

Phase 1Phase 2

Gene Therapy for RPGR Gene Mutation-associated X-linked Retinitis Pigmentosa

X-Linked Retinitis Pigmentosa (XLRP)

Frontera Therapeutics32 enrolled1 locationNCT06492850